Ameliorative effect of NAP on laser-induced retinal damage

Acta Ophthalmologica

Volumn 89, Issue 2, 2011, Pages

  Belokopytov, Mark ^a   Shulman, Shiri ^b   Dubinsky, Galina ^a   Gozes, Illana ^a   Belkin, Michael ^a   Rosner, Mordechai ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Department of Ophthalmology   (Israel)

Author keywords

Laser injury; NAP; Neuroprotection; Rat model; Retina

Indexed keywords

NUCLEOSOME ASSEMBLY PROTEIN; OCTAPEPTIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LASER COAGULATION; MALE; MORPHOMETRICS; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RAT; RETINA INJURY; TISSUE SECTION;

ANIMALS; EYE INJURIES; HOMEODOMAIN PROTEINS; INJECTIONS, INTRAVENOUS; INTRAVITREAL INJECTIONS; LASER COAGULATION; LASERS, GAS; MALE; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; RATS; RETINA;

EID: 79952204631     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.02041.x     Document Type: Article

References (27)

1. Alcalay RN, Giladi E, Pick CG & Gozes I (2004): Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Neurosci Lett 361: 128-131. (Pubitemid 38609233)
2. Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E & Gozes I (2003): The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides 24: 1413-1423. (Pubitemid 38045549)
3. Barkana Y & Belkin M (2000): Laser eye injuries. Surv Ophthalmol 44: 459-478. (Pubitemid 30440780)
4. Bassan M, Zamostiano R, Davidson A et al. (1999): Complete sequence of a novel protein containing a femtomolar-activity- dependent neuroprotective peptide. J Neurochem 72: 1283-1293. (Pubitemid 29085045)
5. Belokopytov M, Ben-Shlomo G, Rosner M, Belkin M, Dubinski G, Epstein Y & Ofri R (2008): Functional efficacy of glatiramer acetate treatment for laser-induced retinal damage in rats. Lasers Surg Med 40: 196-201. (Pubitemid 351500147)
6. Belokopytov M, Belkin M, Dubinsky G, Epstein Y & Rosner M (2010). Development and recovery of laser-induced retinal lesion in rats. Retina 30: 662-670.
7. Beni-Adani L, Gozes I, Cohen Y et al. (2001): A peptide derived from activity dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Pharmacol Exp Ther 296: 57-63. (Pubitemid 32015060)
8. Blat D, Weiner L, Youdim MB & Fridkin M (2008): A novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineuro-degenerative capabilities. J Med Chem 51: 126-134.
9. Brancato R, Pece A, Avanza P & Radrizzani E (1990): Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. Retina 10: 239-243.
10. Divinski I, Mittelman L & Gozes I (2004): A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J Biol Chem 279: 28531-28538. (Pubitemid 38900136)
11. Divinski I, Holtser-Cochav M, Vulih-Schultzman I, Steingart RA & Gozes I (2006): Peptide neuroprotection through specific interaction with brain tubulin. J Neurochem 98: 973-984. (Pubitemid 44051296)
12. Gozes I & Divinski I (2004): The femtomolar- acting NAP interacts with microtubules: novel aspects of astrocyte protection. J Alzheimers Dis 6: S37-S41. (Pubitemid 40202540)
13. Gozes I, Giladi E, Pinhasov A, Bardea A & Brenneman DE (2000): Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharmacol Exp Ther 293: 1091-1098. (Pubitemid 30417880)
14. Gozes I, Alcalay R, Giladi E, Pinhasov A, Furman S & Brenneman DE (2002): NAP accelerates the performance of normal rats in the water maze. J Mol Neurosci 19: 167-170. (Pubitemid 35013351)
15. Gozes I, Steingart RA & Spier AD (2004): NAP mechanisms of neuroprotection. J Mol Neurosci 24: 67-72. (Pubitemid 41359169)
16. Gozes I, Divinski I & Piltzer I (2008): NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42). BMC Neurosci 10: S3.
17. Jehle T, Dimitriu C, Auer S, Knoth R, Vidal- Sanz M, Gozes I & Lagrèze WA (2008): The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol 246: 1255-1263.
18. Liu HF, Gao GH, Wu DC, Xu GD, Shi LS, Xu JM & Wang HB (1989): Ocular injuries from accidental laser exposure. Health Phys 56: 711-716.
19. Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman DE & Gozes I (2000): Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res 854: 257-262. (Pubitemid 30067687)
20. Prendiville PL & McDonnell PJ (1992): Complications of laser surgery. Int Ophthalmol Clin 32: 179-204.
21. Romano J, Beni-Adani L, Nissenbaum OL, Brenneman DE, Shohami E & Gozes I (2002): A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis. J Mol Neurosci 18: 37-45. (Pubitemid 34252622)
22. Shulman S, Belokopytov M, Dubinsky G, Belkin M & Rosner M (2009): Ameliorative effect of PN-277 on laser-induced retinal damage. Graefes Arch Clin Exp Ophthalmol 247: 343-348.
23. Solberg Y, Rosner M, Turetz J & Belkin M (1997): MK-801 has neuroprotective and antiproliferative effects in retinal laser injury. Invest Ophthalmol Vis Sci 38: 1380-1389. (Pubitemid 27278557)
24. Spong CY, Abebe DT, Gozes I, Brenneman DE & Hill JM (2001): Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther 297: 774-779. (Pubitemid 32378011)
25. Steingart RA, Solomon B, Brenneman DE, Fridkin M & Gozes I (2000): VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J Mol Neurosci 15: 137-145. (Pubitemid 32281426)
26. Yoles E & Schwartz M (1998): Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol 153: 1-7. (Pubitemid 28452292)
27. Zemlyak I, Manley N, Sapolsky R & Gozes I (2007): NAP protects hippocampal neurons against multiple toxins. Peptides 28: 2004-2008. (Pubitemid 47419114)